nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adverse event rates as measures of hospital performance—A chance for organizational learning
|
Hauck, Katharina |
|
2012 |
105 |
2-3 |
p. 319-320 2 p. |
artikel |
2 |
A framework to evaluate the effects of small area variations in healthcare infrastructure on diagnostics and patient outcomes of rare diseases based on administrative data
|
Stargardt, Tom |
|
2012 |
105 |
2-3 |
p. 110-118 9 p. |
artikel |
3 |
A new approach to the tradeoff between quality and accessibility of health care
|
Tanke, Marit A.C. |
|
2012 |
105 |
2-3 |
p. 282-287 6 p. |
artikel |
4 |
Challenging Health in All Policies, an action research study in Dutch municipalities
|
Steenbakkers, Mieke |
|
2012 |
105 |
2-3 |
p. 288-295 8 p. |
artikel |
5 |
Contents
|
|
|
2012 |
105 |
2-3 |
p. CO3-CO4 nvt p. |
artikel |
6 |
Does healthcare infrastructure have an impact on delay in diagnosis and survival?
|
Blankart, Carl Rudolf |
|
2012 |
105 |
2-3 |
p. 128-137 10 p. |
artikel |
7 |
Dynamic analysis of interhospital collaboration and competition: Empirical evidence from an Italian regional health system
|
Mascia, Daniele |
|
2012 |
105 |
2-3 |
p. 273-281 9 p. |
artikel |
8 |
Eliminating the shortage of registered nurses in Canada: An exercise in applied needs-based planning
|
Tomblin Murphy, Gail |
|
2012 |
105 |
2-3 |
p. 192-202 11 p. |
artikel |
9 |
Empathy and the application of the ‘unbearable suffering’ criterion in Dutch euthanasia practice
|
van Tol, Donald G. |
|
2012 |
105 |
2-3 |
p. 296-302 7 p. |
artikel |
10 |
Financial burden of drug expenditures in Poland
|
Łuczak, Julita |
|
2012 |
105 |
2-3 |
p. 256-264 9 p. |
artikel |
11 |
Focus on designing health care structures and services for rare diseases
|
Schultz, Carsten |
|
2012 |
105 |
2-3 |
p. 107-109 3 p. |
artikel |
12 |
Health workers at the core of the health system: Framework and research issues
|
Anand, Sudhir |
|
2012 |
105 |
2-3 |
p. 185-191 7 p. |
artikel |
13 |
How do patients with rare diseases experience the medical encounter? Exploring role behavior and its impact on patient–physician interaction
|
Budych, Karolina |
|
2012 |
105 |
2-3 |
p. 154-164 11 p. |
artikel |
14 |
Innovative work behavior in healthcare: The benefit of operational guidelines in the treatment of rare diseases
|
Kessel, Maura |
|
2012 |
105 |
2-3 |
p. 146-153 8 p. |
artikel |
15 |
International comparison of assessments of pharmaceutical innovation
|
Lexchin, Joel |
|
2012 |
105 |
2-3 |
p. 221-225 5 p. |
artikel |
16 |
Is pharmaceutical policy evidence-informed? A case of the deregulation process of nicotine replacement therapy products in Finland
|
Kurko, Terhi |
|
2012 |
105 |
2-3 |
p. 246-255 10 p. |
artikel |
17 |
Japan's policy of promoting end-of-life care in nursing homes: Impact on facility and resident characteristics associated with the site of death
|
Ikegami, Naoki |
|
2012 |
105 |
2-3 |
p. 303-311 9 p. |
artikel |
18 |
Measuring concerns for severity: Re-examination of a health scale with purported equal interval properties
|
Nord, Erik |
|
2012 |
105 |
2-3 |
p. 312-316 5 p. |
artikel |
19 |
Mergers and acquisitions in Western European health care: Exploring the role of financial services organizations
|
Angeli, Federica |
|
2012 |
105 |
2-3 |
p. 265-272 8 p. |
artikel |
20 |
Open innovation in health care: Analysis of an open health platform
|
Bullinger, Angelika C. |
|
2012 |
105 |
2-3 |
p. 165-175 11 p. |
artikel |
21 |
Provision and financing of assistive technology devices in Germany: A bureaucratic odyssey? The case of amyotrophic lateral sclerosis and Duchenne muscular dystrophy
|
Henschke, Cornelia |
|
2012 |
105 |
2-3 |
p. 176-184 9 p. |
artikel |
22 |
Re: “Adverse event rates as measures of hospital performance”—Conflation and confusion with the use of the complications code
|
Kevat, Dev |
|
2012 |
105 |
2-3 |
p. 317-318 2 p. |
artikel |
23 |
Research performance of centers of expertise for rare diseases—The influence of network integration, internal resource access and operational experience
|
Hannemann-Weber, Henrike |
|
2012 |
105 |
2-3 |
p. 138-145 8 p. |
artikel |
24 |
Stakeholder involvement in expensive drug recommendation decisions: An international perspective
|
Rosenberg-Yunger, Zahava R.S. |
|
2012 |
105 |
2-3 |
p. 226-235 10 p. |
artikel |
25 |
Stakeholders involvement by HTA Organisations: Why is so different?
|
Cavazza, Marianna |
|
2012 |
105 |
2-3 |
p. 236-245 10 p. |
artikel |
26 |
The influence of regional health care structures on delay in diagnosis of rare diseases: The case of Marfan Syndrome
|
Roll, Kathrin |
|
2012 |
105 |
2-3 |
p. 119-127 9 p. |
artikel |
27 |
The working status of Japanese female physicians by area of practice: Cohort analysis of taking leave, returning to work, and changing specialties from 1984 to 2004
|
Kodama, Tomoko |
|
2012 |
105 |
2-3 |
p. 214-220 7 p. |
artikel |
28 |
Turnover of registered nurses in Israel: Characteristics and predictors
|
Toren, Orly |
|
2012 |
105 |
2-3 |
p. 203-213 11 p. |
artikel |